Cellyan Biotechnology Co., Ltd

HKPDNASDAQ Capital Market·USD·Closed

HKPDNASDAQ·USD·Closed

$0.44

+8.48%

$0.44

+$0.03 (8.48%)

52W Range

6thpctl

Volume

0.09×avg

Mkt Cap

4.86MUSD

P/E

-6.5TTM

Div Yield

–ann

Healthcare · Medical - Pharmaceuticals

52W Range

6thpctl

Volume

0.09×avg

Market Cap

4.86MUSD

P/E Ratio

-6.5TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+21.7% / yr

Operating margin-4.0%

ROIC-8.9%

Financially safe

Stretched

Debt / equity0.44×

Interest coverage-13.8×

Current ratio2.93×